Microbix Biosystems sues Novartis for Virusmax patent infringement in Europe

Microbix Biosystems Inc., an innovator of biological products and technologies, has commenced a new patent litigation in the Court of Dusseldorf, Germany against Novartis Vaccines and Diagnostics, alleging infringement of its Virusmax patent in Europe. 

Microbix filed its first complaint against Novartis in the Eastern District of Texas on January 6, 2014, alleging infringement of its Virusmax patent in the United States.

 Reference: Microbix Biosystems sues Novartis for Virusmax patent infringement in Europe

Comments

comments